(Q94433420)
Statements
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma (English)
A B Dietz
D J Padley
G W Butler
M L Maas
C W Greiner
D A Gastineau
scientific article published in January 2004
No description defined